Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Reveals Plans For Boosting COVID-19 Vaccine Supplies

More Production Sites Could Be On The Cards

Executive Summary

Members of the European Parliament heard from top EU officials on initiatives being undertaken to strengthen the provision of coronavirus vaccines as member states try to deal with a surge in COVID-19 cases.

You may also be interested in...



Russia’s RDIF and Sberbank Launch $100m Start-Up Fund

Russian sovereign wealth fund and Sputnik V vaccine producer RDIF has teamed up with the country’s biggest bank to fund ‘home-grown’ tech and science-intensive start-ups.

EU Tightens Criteria For Allowing COVID-19 Vaccine Exports

As the coronavirus crisis continues to worsen across Europe, the EU authorities have come up with a new way of determining whether exports of coronavirus vaccines should be allowed.

Coronavirus Notebook: UK Tests Preventative Treatments As Row Escalates With EU Over Vaccine Supply

The procurement and authorization of vaccines are under scrutiny in the European Parliament this week. In the meantime, another Sputnik V spat is taking wing between Russia and the EU, while France has resumed the use of AstraZeneca’s vaccine, but only in the over-55s.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS144042

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel